Radiology Business

SEPTEMBER 20, 2023

Backers include societies representing radiologists and nuclear medicine professionals, device manufacturers, patient advocacy groups, and pharmaceutical companies.

Nuclear Medicine 261

Nuclear Medicine Pharmaceutical Diagnostic Imaging Diagnostic 261

AuntMinnie

JULY 23, 2024

Telix Pharmaceuticals said that the U.S. Through this NDA, Melbourne, Australia-based Telix plans to target underserved populations across the U.S. through its established nuclear pharmacy distribution partnerships and experience, the company said.

Pharmaceutical 246

Pharmaceutical Imaging Healthcare Healthcare 246

AuntMinnie

MARCH 27, 2025

Radiotherapy developer Actinium Pharmaceuticals is launching ATNM-400, a novel, non-prostate-specific membrane antigen (PSMA) targeting radiotherapy for prostate cancer that uses the actinium-225 (Ac-225) radioisotope. Actinium is expecting additional data from Pluvicto-resistant prostate cancer models at the AACR meeting.

Pharmaceutical 147

Pharmaceutical Imaging 147

AuntMinnie

MARCH 25, 2025

Eckert & Ziegler has entered into an agreement with Actinium Pharmaceuticals to supply the firm with the radioisotope actinium-225 (Ac-225). Demand for Ac-225 is driven in part by the rapid development of theranostic "pairs" used in imaging and therapy. and international clinical trials.

Pharmaceutical 130

Pharmaceutical Radiopharmaceuticals Clinic IT 130

Radiology Business

APRIL 17, 2023

For one pharmaceutical company, a plan to independently source barium and iodine from North America may offer protection from global supply chain disruptions.

Pharmaceutical 230

Pharmaceutical Imaging 230

Health Imaging

OCTOBER 23, 2024

The facility will provide much needed developmental and manufacturing support for pharmaceutical companies that produce and distribute medical isotopes.

Pharmaceutical 252

Pharmaceutical Medical 252

Imaging Technology

JANUARY 23, 2024

milla1cf Tue, 01/23/2024 - 13:50 January 23, 2024 — Bayer announced Nelson Ambrogio as the new Head of the Radiology Business at its Pharmaceuticals Division, effective April 1, 2024. He will report to Stefan Oelrich , Member of the Board of Management, Bayer AG, and President Pharmaceuticals.

Pharmaceutical 105

Pharmaceutical Radiology Healthcare Healthcare 105

Radiology Business

AUGUST 26, 2024

The Swiss pharmaceutical firm operates Europe’s second largest network of cyclotrons, used to manufacture radioactive compounds needed for PET scans.

PET Scan 144

PET Scan Pharmaceutical Imaging 144

AuntMinnie

MARCH 21, 2025

Food and Drug Administration (FDA) has approved a new drug application (NDA) for Telix Pharmaceuticals' TLX007-CDx (Gozellix) for prostate cancer imaging. Gozellix will be available alongside Telix's PSMA-PET imaging agent, Illuccix, the firm said.

Pharmaceutical 130

Pharmaceutical Imaging Insurance IT 130

AuntMinnie

SEPTEMBER 12, 2024

The imaging agent fills an unmet need to identify small lesions, which could allow earlier diagnosis of the disease, noted lead author Brian Shuch, MD, of the University of California, Los Angeles, and colleagues. Images available under Creative Commons license (CC BY 4.0 Images available under Creative Commons license (CC BY 4.0

Pharmaceutical 279

Pharmaceutical Diagnose Imaging Clinic 279

Imaging Technology

SEPTEMBER 20, 2023

We designed RXM-4768 with the unique requirements for SCINTIX therapy in mind, and our preclinical data demonstrated its potential as an effective biology guide for potentially most solid tumor cancer types,” said Dr. Ulrich Reineke , founder & managing director of 3B Pharmaceuticals. “We

Pharmaceutical 105

Pharmaceutical Radiopharmaceuticals Radiation Diagnostic 105

AuntMinnie

OCTOBER 18, 2024

Australia-based Telix Pharmaceuticals has filed with the U.S. For the quarter (end-September 30), Telix reported: Total revenue of approximately $135 million ($201 million AUD), primarily generated from sales of Telix’s prostate cancer imaging product Illuccix in its precision medicine (Px) business unit.

Pharmaceutical 246

Pharmaceutical IT Diagnostic Imaging 246

AuntMinnie

MARCH 7, 2025

The group analyzed flortaucipir (Tauvid, Avid Pharmaceuticals) PET scans acquired over a 3.5-year Moreover, currently, approximately a quarter of postmenopausal women who are 70 years and older have a history of HT use and have now entered a critical age of risk for Alzheimers disease, the authors added.

Disease 162

Disease PET Scan Pharmaceutical Education 162

AuntMinnie

JANUARY 2, 2025

Telix Pharmaceuticals and the Brussels-based Oncidium foundation are highlighting results from the NOBLE Registry of TLX599-CDx (technetium-99m [Tc-99m] inhibitor of prostate-specific membrane antigen [iPSMA]), published in the European Journal of Nuclear Medicine and Molecular Imaging Reports. No adverse events were reported.

Nuclear Medicine 130

Nuclear Medicine Imaging Pharmaceutical Clinic 130

AuntMinnie

MAY 19, 2024

Lantheus Medical Imaging has appointed a new chief medical officer (CMO) and a new chief science officer (CSO). He will oversee Lantheus’ research and development organization, including research and pharmaceutical development, regulatory affairs, clinical development, medical affairs, and isotope strategy.

Pharmaceutical 130

Pharmaceutical Medical Imaging Medical Clinic 130

AuntMinnie

SEPTEMBER 18, 2024

Telix Pharmaceuticals has selected Cardinal Health to distribute its PET agent TLX250-CDx (Zircaix) for imaging kidney cancer in the U.S., subject to its regulatory approval. If approved , Zircaix will be the first targeted PET agent specifically for kidney cancer to be commercially available in the U.S., the company noted.

Pharmaceutical 147

Pharmaceutical Disease Diagnostic IT 147

AuntMinnie

OCTOBER 30, 2024

GE HealthCare (GEHC) reported a 1% growth in existing operation revenues and an increase in profitability in its second quarter of 2024, citing solid performance in its Pharmaceutical Diagnostics segment. On an individual segment basis, GE HealthCare's Imaging segment had flat revenues year over year of $2.22 last year to 16.3%

Healthcare 130

Healthcare Healthcare Pharmaceutical Ultrasound 130

Keosys Medical Imaging

AUGUST 26, 2024

With her large experience in the pharmaceutical industry, Helen Blanco currently serves as Chief Operating Officer at Node Pharma , a preclinical radiopharmaceutical company based in Norway. Here is another excerpt from our conversation.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals 52

AuntMinnie

JULY 31, 2024

On an individual segment basis, GE HealthCare's Imaging segment had revenues of $2.596 billion, down 1% from $2.62 However, organic imaging revenue was $2.62 Imaging EBIT increased by 3% to reach $286 million. Pharmaceutical Diagnostics segment EBIT was $200 million, up 31% over last year. last year to 15.3%

Healthcare 130

Healthcare Healthcare Pharmaceutical Ultrasound 130

AuntMinnie

AUGUST 27, 2024

Telix Pharmaceuticals has submitted a new drug application (NDA) with the U.S. Food and Drug Administration (FDA) for its PET radiotracer TLX101-CDx (Pixclara) for imaging brain cancer. Earlier this year, the FDA granted TLX101-CDx fast-track designation, as well as opened an expanded access program for the imaging agent.

Pharmaceutical 130

Pharmaceutical Imaging IT 130

AuntMinnie

JANUARY 24, 2024

Enigma Biomedical Group USA (EBG-USA) has signed an exclusive agreement to commercialize AbbVie’s tau PET imaging biomarkers for use in patients with suspected neurodegenerative disease. Tau ligands labeled with F-18 radioisotopes are used as radiotracers during PET imaging to visualize this pathology.

Pharmaceutical 147

Pharmaceutical Disease Clinic Imaging 147

AuntMinnie

AUGUST 31, 2023

Radiotherapy developer Actinium Pharmaceuticals will present three abstract. Read more on AuntMinnie.com Related Reading: Actinium highlights six abstracts at SNMMI 2023 Actinium, Astellas to create actinium-225 radiotherapies SNMMI 2020: PET tracer could image, treat glioblastoma Zevacor signs on as manufacturing partner for Actinium

Pharmaceutical 130

Pharmaceutical Imaging 130

AuntMinnie

JUNE 19, 2023

The first patient has been dosed in Telix Pharmaceuticals' carbonic anhydrase-targetin. Telix gets FDA nod for gallium injection prep kit Telix makes two new executive appointments Telix highlights kidney cancer imaging study results Telix relocates U.S. Read more on AuntMinnie.com Related Reading: Telix acquires Dedicaid for $1.2M

Pharmaceutical 130

Pharmaceutical Imaging 130

AuntMinnie

OCTOBER 22, 2024

The 52,000-sq-ft facility will provide biopharmaceutical and pharmaceutical companies with development services and dose manufacturing capacity for key imaging and therapeutic radioisotopes, including actinium-225, lutetium-177, copper-64, copper-67, and indium-111, among others, the company said.

Pharmaceutical 130

Pharmaceutical Radiopharmaceuticals Medical IT 130

AuntMinnie

AUGUST 22, 2024

Food and Drug Administration (FDA) has granted Clarity Pharmaceuticals fast-track designation for its copper-64 (Cu-64) sarcophagine (SAR) bisPSMA radiopharmaceutical.

Pharmaceutical 130

Pharmaceutical Radiopharmaceuticals Disease Clinic 130

AuntMinnie

APRIL 27, 2023

Telix Pharmaceuticals has acquired Vienna, Austria-based Dedicaid, a spin-of. Read more on AuntMinnie.com Related Reading: Telix gets FDA nod for gallium injection prep kit Telix makes two new executive appointments Telix highlights kidney cancer imaging study results Telix relocates U.S.

Pharmaceutical 130

Pharmaceutical Imaging 130

AuntMinnie

JUNE 21, 2023

Telix Pharmaceuticals has entered a $20 million agreement to acquire th. Telix gets FDA nod for gallium injection prep kit Telix makes two new executive appointments Telix highlights kidney cancer imaging study results

Pharmaceutical 130

Pharmaceutical Medical Imaging 130

AuntMinnie

OCTOBER 22, 2024

Telix Pharmaceuticals plans to spin off its wholly-owned subsidiary Rhine Pharma and structure it as an independent company. Rhine Pharma’s mission will be to expand global access to radiopharmaceuticals for cancer imaging and treatment using two generator-produced isotopes, technetium-99m (Tc-99m) and rhenium-188 (Re-188), the company said.

Pharmaceutical 130

Pharmaceutical Radiopharmaceuticals Hospital Clinic 130

AuntMinnie

JULY 18, 2024

Melbourne, Australia-based Telix Pharmaceuticals reported a spike in revenue for the second quarter of 2024, citing strong sales of Illuccix (gallium-68 prostate-specific membrane antigen [PSMA]-11), its PSMA-PET radiotracer kit for prostate cancer imaging.

Pharmaceutical 130

Pharmaceutical IT Imaging 130

AuntMinnie

FEBRUARY 19, 2025

Clarity Pharmaceuticals has secured fast-track designation from the U.S. The classification builds on Clarity's earlier receipt of fast-track designation for its PET diagnostic imaging agent Cu-64 SAR-bisPSMA for identifying patients with the disease.

Radiopharmaceuticals 130

Radiopharmaceuticals Pharmaceutical Disease Diagnostic Imaging 130

Open Medscience

OCTOBER 1, 2024

ICH Q10 is a global model for managing pharmaceutical quality, ensuring compliance, continuous improvement, and risk manage The post The International Council for Harmonization (ICH) Q10: A Model for a Robust Pharmaceutical Quality Management System appeared first on Open MedScience.

Pharmaceutical 52

Pharmaceutical Quality and Compliance Risk Management Radiopharmaceuticals 52

AuntMinnie

JUNE 14, 2024

Clinical trials for MASH drugs rely on various imaging modalities to provide quantitative and qualitative data regarding liver health, fat content, fibrosis, and inflammation. Imaging techniques serve as invaluable tools for evaluating treatment efficacy and disease progression over time.

Imaging 130

Imaging Imaging Modalities Disease Medical Imaging 130

AuntMinnie

MARCH 5, 2024

Telix Pharmaceuticals has entered an agreement to acquire Canadian diagnostic imaging isotopes company ARTMS for $82 million. The companies have been collaborating since 2020 to develop higher curie-scale production of Illuccix, a PET radiotracer injection kit used for prostate cancer imaging.

Pharmaceutical 130

Pharmaceutical Diagnostic Imaging Diagnostic Imaging 130

AuntMinnie

JANUARY 30, 2024

For many, machine learning's potential is more than just talk; the power of well-trained, image-augmented AI has already been demonstrated as a useful tool for quality control, disease tracking, tumor segmentation, and making prognosis predictions.

Medical Imaging 154

Medical Imaging Medical Radiology Imaging 154

AuntMinnie

APRIL 17, 2024

Food and Drug Administration (FDA) has granted fast-track designation to Telix Pharmaceuticals’ PET radiotracer F-18 floretyrosine (Pixclara) for imaging progressive or recurring gliomas. Pixclara was developed by researchers at the University of California, San Francisco.

Pharmaceutical 130

Pharmaceutical MRI IT Imaging 130

Imaging Technology

JULY 24, 2024

mtaschetta-millane Wed, 07/24/2024 - 11:17 July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) has accepted the filing of its New Drug Application (NDA) for TLX007-CDx, a new and proprietary cold kit ("Kit") for the preparation of PSMA-PET imaging[1] for prostate cancer.

Imaging 105

Imaging Bone Scan Pharmaceutical Healthcare 105

Keosys Medical Imaging

AUGUST 26, 2024

With her large experience in the pharmaceutical industry, Helen Blanco currently serves as Chief Operating Officer at Node Pharma , a preclinical radiopharmaceutical company based in Norway. We recently spoke with Helen about the key criteria when selecting an imaging vendor and exciting upcoming innovations in the oncology space.

Pharmaceutical 98

Pharmaceutical Radiopharmaceuticals Imaging Medical Imaging 98